Department of Neurology, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
Sleep Breath. 2012 Dec;16(4):1237-45. doi: 10.1007/s11325-011-0640-8. Epub 2011 Dec 31.
Restless legs syndrome (RLS) has a broad worldwide prevalence between 0.01% and 18.3%. While differences in RLS definitions and data ascertainment methods account for some variability, other factors likely contribute. The circadian nature of RLS and the fact that RLS symptoms track with endogenous melatonin levels suggest that light or ultraviolet radiation (UVR) may be related to RLS expression. As the amount of UVR decreases with latitude, we considered the potential effect of geography on RLS prevalence with the thought being that RLS prevalence rises with increasing latitude.
RLS epidemiologic studies were sought via Pubmed search in the period between January 1, 1992 and November 15, 2010. Prevalence was mapped for each country or specific region studied and examined by continent. Pearson's correlational testing was carried out for RLS prevalence and latitude of the region studied.
Global RLS prevalence ranges from 0.01% in Africa, 0.7% to 12.5% in Asia, 2.0% to 18.9% in the Americas, and 3.2% to 18.3% in Europe. Mapping RLS prevalence by country or region in both the Americas and in Europe suggests increasing RLS frequency with greater northern latitude. RLS prevalence is positively correlated with northern latitude in both North America and Europe with correlation coefficients of r = 0.77 (0.15, 0.96; p = 0.02) and r = 0.74 (0.44, 0.89; p = 0.0002), respectively. In Europe, lower latitudinal countries like Greece and Turkey had RLS prevalence (per 1,000 persons) of 38 and 34, respectively, middle latitudinal countries like France and England of 108 and 86, respectively, and high latitudinal countries like Norway and Iceland of 143 and 183, respectively.
RLS epidemiology indicates an increase in RLS frequency in northern latitudinal countries as a function of distance from the equator, an effect most evident in Europe. This suggests that factors that track with latitude like UVR may be involved in the expression of RLS.
不宁腿综合征(RLS)的全球患病率在 0.01%至 18.3%之间。虽然 RLS 的定义和数据确定方法的差异解释了部分变异性,但其他因素可能也有影响。RLS 的昼夜节律性质以及 RLS 症状与内源性褪黑素水平相关的事实表明,光或紫外线(UVR)可能与 RLS 的表达有关。随着纬度的增加,UVR 的量减少,我们考虑了地理位置对 RLS 患病率的潜在影响,认为 RLS 患病率随着纬度的增加而升高。
通过在 1992 年 1 月 1 日至 2010 年 11 月 15 日期间在 Pubmed 上进行检索,寻找 RLS 的流行病学研究。对每个研究的国家或特定地区的患病率进行了绘制,并按大陆进行了检查。对 RLS 患病率和研究区域的纬度进行了 Pearson 相关性检验。
全球 RLS 患病率范围从非洲的 0.01%,亚洲的 0.7%至 12.5%,美洲的 2.0%至 18.9%,欧洲的 3.2%至 18.3%。在美洲和欧洲,按国家或地区绘制 RLS 患病率图表明,随着纬度的增加,RLS 的频率也随之增加。RLS 患病率与北纬度呈正相关,在北美和欧洲的相关系数分别为 r=0.77(0.15,0.96;p=0.02)和 r=0.74(0.44,0.89;p=0.0002)。在欧洲,像希腊和土耳其这样低纬度的国家,RLS 患病率(每 1000 人)分别为 38 和 34,而像法国和英国这样中纬度的国家,RLS 患病率分别为 108 和 86,像挪威和冰岛这样高纬度的国家,RLS 患病率分别为 143 和 183。
RLS 的流行病学表明,随着离赤道距离的增加,RLS 的频率在高纬度国家增加,这在欧洲最为明显。这表明,与纬度相关的因素,如 UVR,可能与 RLS 的表达有关。